{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-2175-0006", "FDA", "FDA-2014-D-2175", "Reference 3 Mitchell-1984-Physicochemical Inactivation of Lassa, Ebola, and Marburg Viruses and Effect on Clinical Laboratory Analyses  re Recommendations for Assessment of Blood Donor Suitability, Donor Deferral and Blood Product Management in Response to Ebola Virus; Draft Guidance for Industry; Availability", "Supporting & Related Material", "Background Material", "2015-12-07T05:00:00Z", 2015, 12, null, null, "2015-12-07T14:38:57Z", null, 0, 0, "0900006481d83cbb"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-2175-0006"], "units": {}, "query_ms": 0.3257310017943382, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}